On average, 7 out of 10 retail investors suffer losses when trading turbo certificates. Turbo certificates are highly risky products and are not suited for long-term investment strategies.
6.051 - 6.075 of 94.502
- Product
- Maturity
- Leverage (Omega)
- Sell
- Buy
- Costco Call 960,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,53x
- Analysis
- Gilead Sciences Call 195,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 3,86x
- Analysis
- Regeneron Pharmaceuticals Call 1.030,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 3,46x
- Analysis
- Eli Lilly Put 2.000,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 1,04x
- Analysis
- Regeneron Pharmaceuticals Call 1.030,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 3,28x
- Analysis
- Mercadolibre Call 1.480,00 17 Dec 2027
- Goldman Sachs
- 17.12.27
- 2,80x
- Analysis
- Costco Call 940,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,50x
- Analysis
- Regeneron Pharmaceuticals Call 1.020,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,57x
- Analysis
- Illumina, Inc. Call 225,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 1,75x
- Analysis
- Intel Put 40,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 1,31x
- Analysis
- Eli Lilly Put 2.000,00 16 Mar 2029
- Goldman Sachs
- 16.03.29
- 1,02x
- Analysis
- Alphabet - Class A Call 250,00 16 Mar 2029
- Goldman Sachs
- 16.03.29
- 2,12x
- Analysis
- General Mills Call 39,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,82x
- Analysis
- Alphabet - Class A Call 250,00 16 Jun 2028
- Goldman Sachs
- 16.06.28
- 2,44x
- Analysis
- Eli Lilly Call 2.400,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 4,11x
- Analysis
- Alphabet Call 250,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,14x
- Analysis
- Eli Lilly Call 2.400,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,79x
- Analysis
- Eli Lilly Call 1.640,00 15 Dec 2028
- Goldman Sachs
- 15.12.28
- 2,49x
- Analysis
- Gilead Sciences Call 195,00 15 Sep 2028
- Goldman Sachs
- 15.09.28
- 2,97x
- Analysis
- Caterpillar Inc Call 600,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 6,00x
- Analysis
- Alphabet - Class A Put 250,00 16 Mar 2029
- Goldman Sachs
- 16.03.29
- 2,08x
- Analysis
- SNDK UW Put 75,00 19 Mar 2027
- Goldman Sachs
- 19.03.27
- 1,56x
- Analysis
- SNDK UW Put 75,00 17 Mar 2028
- Goldman Sachs
- 17.03.28
- 0,73x
- Analysis
- Costco Call 1.080,00 19 Jan 2029
- Goldman Sachs
- 19.01.29
- 2,75x
- Analysis
- Regeneron Pharmaceuticals Call 1.010,00 21 Jan 2028
- Goldman Sachs
- 21.01.28
- 3,23x
- Analysis